Member Info for unvrkw

Still under value, worth more and nhs is chaos

money going into health care, defensive stock against finance and oil

I wonder why? Another blue day and the rise keeps going, hope to hit the one pound sometime soon but at the same time retrace?

i bought into circle holdings recently and whilst i dont wish to create a downwards spiral, its drifted up by around 150% in the last few weeks and doesnt seem to stop. i think worth minimum £1 on this tick up, more to follow. great share, great area and quite defensive, sits well in a portfolio alongside shares like FOX. gla

Omega Diagnostics Group PLC are pleased to announce that Visitect CD4 has been chosen for the inaugural Nominet Trust 100 – a list that celebrates the people and organisations who are utilising digital technology to change the world for the better. Visitect CD4 was selected from hundreds of nominations reviewed by the Nominet Trust 100 Steering Group, which this year included; Lord Jim Knight (a consultant specialising in the use of technology in education and employment), Rory Cellan-Jones (Technology Journalist for the BBC), Madhav Chavan (a leading Indian educator, social activist and social entrepreneur) and Jeremy Heimans (Founder and CEO of Purpose). We hope you will join us in celebrating this great achievement. They are pumping India and china big time!! The sales are in the bank I believe it's getting the final hurdle of the process

Good movement today and I can't quite believe no retrace. Think this has another 70 pence to go over the next few months. Nice.....

We recognise that our ability to make a step change of our future growth is highly predicated on successful outcomes of both our CD4 and IDS-iSYS projects and we are at sufficiently advanced stages with both projects to be very confident that both will deliver significant shareholder value in the next financial year." Sales up, profit up, very good margin amounts, next year all records broken

off the radar, not invested in heavily, not sure but the SP is marching on, i question whether it will stabilise and go backwards slightly. i learnt badly not to sell into a rising SP so i am hanging on. first investment now over 120% and the rest well in profit. the business needs to announce positive moves, saying that i believe the SP was too low anyway and did not reflect the current status. profitable business, another placing for expansion?? maybe, we shall see.

Board update good and strong tones and understsndable expectations. Slow climb north, expect the progress to continue and I read that sales are easily possible if the products are realised and practical. They sound confident in this area, still a buy, no great need for new funding unless great , positive expansion, they are making solid profit, expect next year to double if new areas are realised.

This drifts down against my Barclays which are heading north. Might switch out soon into fox and gain in new year. It's seems very much in control, raw material available, settled and selling taking place. Will watch a little longer, see how December takes us and then buy more

And the climb back to previous levels continues. No updates to the bad, deals must be hopefully progressing and a few months until hitchinbrooke breaks even. Suggest by Xmas rather than march, nhs continues to go all over the place. Suggest this business has a very long and potentially fruitful life, more work, more contracts and integration with the nhs. Limited shares also available, no new funding in near future unless for significant expansion and £1 easy target.

Agree I like this and everyone talks about off the radar. I am in circle plc, fox marble and cic capital in the AIM market. All I think are or will do well, off and on the radar but doing ok in these and worth waiting for. Health care with omega and circle. Building with fox marble and cic capital is mining.

I think we will see upward strength over the next few months if delays are not announced. Revenue and profit next year will be ahead of expectations and get announced. As stated, next year will be breakthrough and I expect this to be the case. They have some momentum, keen interest in the products and I note extensive sale travel to promote and increasing team in Asia.

Starting to make a little head way now. Averaged down and bought at 29 so going well and good to double money in the next few weeks. No idea in the charts but seems to have good, steady upward momentum. Nothing reported but expect contract close out, new hospital arrangements and I believe better than expected results. Good share, future bright, busy and lots if cash involved, the nhs needs businesses like circle, that's a fact.

Looks ok and they seem very confident that next year will go well and revenue increased. Intend to hold and see an increase.

We need to know everything is on track for year end and growth 2014. Big update this next week that needs to go well. GLA

Everything declared to be bought within raise money so far. I wonder whether more is needed to find equipment at other mines or they will now finance from within ? A declaration of selling and income will be good, break even of course even better by q2 next year? By then everything being done in house at minimum cost and max production on desired mines. I hope this beomces quite a steady balanced share, defensive in nature but with good upside due to the startup and their location.

I can only see a bad winter causing problems here of political uncertainty. If bad weather then I assume they shut down and await the thaw. After this and during sales will be created ready for the spring and full production, break even, 2014 for sure.

I understand the gold marble reference is the very expensive one which is quite rare? Pretty simple now, need lots of Russian and Chinese to buy big quantities, cost will reduce by end of Q1 2014 with their own on site facilities and quarrying can continue to generate good profit!

Overall, we anticipate that revenues for the full year will show modest growth year on year, with pre-exceptional profit in line with the prior financial year, and that our second half net direct placements will pick up materially over the first half. We continue to pursue our three strategic initiatives: increasing the menu of assays available on the IDS-iSYS, improving our instrumentation through the development of the mark II IDS-iSYS and building our presence in the emerging markets. We continue to make good progress in all of these areas and will provide a full update with the interim results announcement on 27 November 2013